欧美综合自拍亚洲综合网_欧美黑人巨大videos异族_可乐操中文字幕_亚洲成av人福利专区网站_国产强奸视频在播放_免费无码国产在线53_最近最新的免費中文字幕_抖音免费视频素材_亚洲精品熟女一二区_国产无套粉嫩白浆在线麻豆

表皮生長因子受體(EGFR)單克隆抗體

Monoclonal Antibody to Epidermal Growth Factor Receptor (EGFR)

ErbB-1; ErbB1; ER1; ERB-B1; MENA; HER1; Erythroblastic Leukemia Viral(v-Erb-B)oncogene Homolog,Avian; Proto-oncogene c-ErbB-1; Receptor tyrosine-protein kinase erbB-1

  • 表皮生長因子受體(EGFR)單克隆抗體 產(chǎn)品包裝(模擬)
  • 表皮生長因子受體(EGFR)單克隆抗體 產(chǎn)品包裝(模擬)
  • 表皮生長因子受體(EGFR)單克隆抗體 Western Blot; Samples: Lane1: Hela cell lysate; Lane2: A431 cell lysate;
    Primary Ab: 0.02μg/ml Mouse Anti-Human EGFR Antibody
    Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
    (Catalog: SAA544Mu19)
  • Certificate 通過ISO 9001、ISO 13485質(zhì)量體系認證

特異性

該抗體是針對EGFR的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別EGFR。

用法

Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.

儲存

經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。

贈品

相關(guān)產(chǎn)品

編號 適用物種：Homo sapiens (Human，人) 應(yīng)用(僅供研究使用，不用于臨床診斷！)
APA757Hu01 表皮生長因子受體(EGFR)活性蛋白 Cell?culture;?Activity?Assays.
APA757Hu02 表皮生長因子受體(EGFR)活性蛋白 Cell?culture;?Activity?Assays.
APA757Hu62 表皮生長因子受體(EGFR)活性蛋白 Cell?culture;?Activity?Assays.
RPA757Hu01 表皮生長因子受體(EGFR)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
APA757Hu61 表皮生長因子受體(EGFR)活性蛋白 Cell?culture;?Activity?Assays.
EPA757Hu62 表皮生長因子受體(EGFR)真核蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPA757Hu02 表皮生長因子受體(EGFR)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
EPA757Hu61 表皮生長因子受體(EGFR)真核蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAA757Hu06 表皮生長因子受體(EGFR)多克隆抗體 WB; IHC; ICC; IP.
PAA757Hu02 表皮生長因子受體(EGFR)多克隆抗體 WB; IHC; ICC; IP.
PAA757Hu01 表皮生長因子受體(EGFR)多克隆抗體 WB; IHC; ICC; IP.
FAA757Hu51 抗表皮生長因子受體(EGFR)多克隆抗體(別藻藍蛋白標記) FCM
MAA757Hu27 表皮生長因子受體(EGFR)單克隆抗體 WB; IHC; ICC; IP.
MAA757Hu29 表皮生長因子受體(EGFR)單克隆抗體 WB; IHC; ICC; IP.
RAA757Hu21 表皮生長因子受體(EGFR)重組抗體 WB; IF; ICC; IHC; IP; FCM.
MAA757Hu21 表皮生長因子受體(EGFR)單克隆抗體 WB; IHC; ICC; IP.
MAA757Hu23 表皮生長因子受體(EGFR)單克隆抗體 WB; IHC; ICC; IP.
MAA757Hu24 表皮生長因子受體(EGFR)單克隆抗體 WB; IHC; ICC; IP.
MAA757Hu25 表皮生長因子受體(EGFR)單克隆抗體 WB; IHC; ICC; IP.
MAA757Hu22 表皮生長因子受體(EGFR)單克隆抗體 WB; IHC
SEA757Hu 表皮生長因子受體(EGFR)檢測試劑盒(酶聯(lián)免疫吸附試驗法) Enzyme-linked immunosorbent assay for Antigen Detection.
HEA757Hu 表皮生長因子受體(EGFR)檢測試劑盒(酶聯(lián)免疫吸附試驗法,高敏型) Enzyme-linked immunosorbent assay for Antigen Detection.
AEA757Hu 抗表皮生長因子受體抗體(Anti-EGFR)檢測試劑盒(酶聯(lián)免疫吸附試驗法) Enzyme-linked immunosorbent assay for Antibody Detection.
LMA757Hu 表皮生長因子受體(EGFR)等多因子檢測試劑盒(流式熒光發(fā)光法) FLIA Kit for Antigen Detection.

參考文獻

雜志 參考文獻
Thoracic Cancer Nimotuzumab combined with gemcitabine and cisplatin as second-line chemotherapy for advanced non-small-cell lung cancer [Wiley: source]
J Cent Nerv Syst Dis.? Increased Epidermal Growth Factor Receptor (EGFR) Associated with Hepatocyte Growth Factor (HGF) and Symptom Severity in Children with Autism … [Pubmed:25249767]
Mol Cancer Ther GC1118, an anti-EGFR antibody with a distinct binding epitope and superior inhibitory activity against high-affinity EGFR ligands [PubMed: 26586721]
Cell Death Dis.? LINC01225 promotes occurrence and metastasis of hepatocellular carcinoma in an epidermal growth factor receptor-dependent pathway [Pubmed:26938303]
analytica chimica acta Microfluidic immunosensor based on mesoporous silica platform and CMK-3/poly-acrylamide-co-methacrylate of dihydrolipoic acid modified gold electrode for cancer biomarker detection. [pubmed:28335979]
Talanta EGFR detection in extracellular vesicles of breast cancer patients through immunosensor based on silica-chitosan nanoplatform [Doi: 10.1016/j.talanta.2018.10.016]
Bioorganic Chemistry Design, synthesis, molecular docking and biological activity evaluation of some novel indole derivatives as potent anticancer active agents and apoptosis inducers [Pubmed: 30665034]
Journal of?enzyme?inhibition and medicinal chemistry Novel thienopyrimidine derivatives as dual EGFR and VEGFR-2 inhibitors: design, synthesis, anticancer activity and effect on cell cycle profile [Pubmed: 30919701]
Bioorganic Chemistry Design and synthesis of new benzoxazole/benzothiazole-phthalimide hybrids as antitumor-apoptotic agents []
Bioorganic Chemistry Synthesis and anticancer activity of bis-benzo [d][1, 3] dioxol-5-yl thiourea derivatives with molecular docking study [Pubmed: 31288134]
Oxidative Medicine and Cellular Longevity Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters?… [Pubmed: 31737175]
Neoplasia Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine [Pubmed: 33212364]
Association between Serum Epidermal Growth Factor Receptor and Cyclooxygenase-2 Levels in Patients with Non-small Cell Carcinoma of Lung []
Synthesis, EGFR-TK inhibition and anticancer activity of new quinoxaline derivatives []
IMMUNOLOGIC RESEARCH Humoral immune response to epidermal growth factor receptor in lung cancer [33495907]
European Journal of Medicinal Chemistry Pyrazolo[3,4-d]pyrimidine-based dual EGFR T790M/HER2 inhibitors: Design, synthesis, structure¨Cactivity relationship and biological activity as potential antitumor and anticonvulsant agents [33545637]
Journal of Molecular Structure Design, synthesis, antiproliferative evaluation, and molecular docking study of new quinoxaline derivatives as apoptotic inducers and EGFR inhibitors []
ACS Appl Mater Interfaces Emitter–Quencher Pair of Single Atomic Co Sites and Monolayer Titanium Carbide MXenes for Luminol Chemiluminescent Reactions [34914377]
Bioorganic Chemistry Discovery of new pyrimido [5, 4-c] quinolines as potential antiproliferative agents with multitarget actions: Rapid synthesis, docking, and ADME studies [Pubmed:35219045]
留言咨詢